Loading organizations...
Key people at Adage.
Key people at Adage.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 9, 2025 | Expedition Therapeutics | $165.0M Expedition Therapeutics Series A | Novo Holdings, Sofinnova Ventures, Ken Harrison, Jonathan Leff, Ken Harrison, Jonathan Leff | Balyasny Asset Management, Gorjan Hrustanovic, Dawn Biopharma, Regina Salvat, Logos Capital, Sanofi Ventures, Venrock |
| May 18, 2021 | PathAI | $165.0M Series C | Daniel Saul Sundheim, Kaiser Permanente | 8VC, Biospring Partners, Bristol Myers Squibb, General Atlantic, General Catalyst, GHI, KdT Ventures, Labcorp, Polaris Partners, Refactor Capital, Tiger Global |
| Apr 1, 2021 | Arcellx | $120.0M Series C | Samsara BioCapital, CAM Capital | Genoa Ventures, Asymmetry Ventures, CaaS Capital Management, Cambrian Biopharma, LG Tech, NEA, Novo Holdings, Sixty Degree Capital, SR One, Surveyor Capital, Suvretta Capital Management, Takeda Ventures, Terra Magnum Capital Partners |